CARDENE I.V.
Commercial- Indications
- Hypertension
Company intelligence / Profile preview
EKR Therapeutics
Bedminster, New Jersey, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
EKR Therapeutics was a specialty pharmaceutical company that acquired and commercialized acute-care products. Their portfolio included Cardene (antihypertensive), Retavase (for acute myocardial infarction), DepoDur (injectable morphine for post-operative pain), and Gelclair (bioadherent oral gel for oral mucositis).
- Therapeutic areas
- GastroenterologyCardiovascularNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on EKR Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EKR Therapeutics.